📈 Jumpstart Signal Watchlist — July 27, 2026

🏢 What they do: Bioventus Inc. is a global medical device company that develops and commercializes clinically proven, minimally invasive products to relieve pain and address musculoskeletal challenges by enhancing the body's natural healing process .
- 🎯 Current $12.45 is 9% below 3yr high $13.71 · ⏳ SMA200 $8.65 (current price $12.45 is above) · 💰 Market Cap $838M
- BVS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 43/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 200% (>20%); ROE 15% (>15%); Near-high ROE setup (52wk high + ROE); PEG ratio 0.15 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (9.6%)
- 🔔 Strong above EMA50 (17.8%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (mixed coverage).
✅ Bioventus shares rise after Medicare reverses reimbursement cuts — Investing.com.
🤖 Bioventus shares climbed as much as 13% after CMS reversed previously issued reimbursement cuts for the company’s non-invasive bone growth stimulators. The reversal directly improves the reimbursement backdrop for a key product category and is likely supportive for revenue expectations.
✅ Hillsdale Investment Management Inc. Raises Stake in Bioventus Inc. $BVS — MarketBeat.
🤖 This filing-based story says Hillsdale Investment Management increased its Bioventus holdings by 148.7% in the first quarter. The article also highlights Bioventus’s stronger-than-expected quarterly EPS and raised FY2026 guidance, both of which are favorable signals for the stock.
❌ Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders? — PR Newswire.
🤖 This report says a law firm is investigating whether Bioventus officers and directors breached fiduciary duties to shareholders. Such investigations can increase legal overhang and uncertainty, which is typically negative for the stock.
🍭 Bonus (B): 0/10 — Surgical & Medical Instruments

🏢 What they do: Ooma, Inc. provides cloud-based VoIP phone systems and unified communications services for businesses and consumers, featuring voice, messaging, video, and AI tools like call transcriptions and answering services. Their primary offerings include Ooma Office for small to mid-sized businesses, Ooma AirDial for POTS line replacement, and Ooma Telo for affordable residential landline service.
- 🎯 Current $20.78 is 1% below 3yr high $20.97 · ⏳ SMA200 $14.26 (current price $20.78 is above) · 💰 Market Cap $569M
- OOMA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (14.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1000% (>20%); Revenue growth 25% (>15%); Low LT D/E 0.50 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (10.4%)
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Ooma (OOMA) Stock Price, News & Analysis — MarketBeat.
🤖 The page highlights Ooma’s recent earnings beat, with revenue and EPS both above estimates, and notes the stock’s strong year-to-date move. It also lists recent company-specific items such as the Travelers Care award, which supports a positive tone overall.
✅ Ooma (OOMA) Beats Q4 Earnings and Revenue Estimates — Zacks.
🤖 Ooma reported quarterly EPS and revenue above analyst expectations, which is generally favorable for the stock. The article emphasizes repeated earnings surprises, reinforcing a positive read-through for investor sentiment.
⚪️ Ooma SVP & chief legal officer Jenny Yeh sells ... — Investing.com.
🤖 This article reports an insider stock sale by Ooma’s SVP and chief legal officer, which is typically a mixed signal and does not by itself change the company’s fundamentals. The piece also cites Ooma’s recent strong quarterly results and bullish analyst revisions, but the direct news item is the insider sale.
⚪️ Hsbc Holdings PLC Buys 50,114 Shares of Ooma, Inc. $ ... — MarketBeat.
🤖 This is primarily an institutional ownership update, noting that HSBC increased its Ooma stake in a prior reporting period. It does not describe a new operational development or earnings event, so the stock impact is limited and mostly informational.
🍭 Bonus (B): 10/10 — Computer Processing & Data Prep (Technology sector)

🏢 What they do: John Wiley & Sons, Inc. (Wiley) is a global research and learning company that publishes over 1,900 peer-reviewed scientific, technical, medical, and scholarly journals along with academic and professional books, encyclopedias, and digital content .
- 🎯 Current $51.01 is 4% below 3yr high $53.13 · ⏳ SMA200 $37.75 (current price $51.01 is above) · 💰 Market Cap $2.7B
- WLY shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (8.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 103% (>20%); ROE 26% (>15%); Low LT D/E 0.81 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Wiley Raises Dividend for 33rd Consecutive Year, Powered by Research and AI Momentum, Record Margins, and Strong Cash Flow — Investing.com.
🤖 The article says Wiley beat fiscal Q4 adjusted EPS estimates, highlighted record margins and stronger cash generation, and raised its quarterly dividend. Those are generally supportive signals for $WLY because they suggest solid profitability and shareholder returns.
✅ John Wiley & Sons (WLY) Stock Price, News & Analysis — MarketBeat.
🤖 This page notes that Wiley’s latest earnings beat consensus EPS and that it recently increased its quarterly dividend. It is positive for $WLY because it reflects better-than-expected profitability and continued capital returns to shareholders.
✅ The Bull Case For John Wiley & Sons (WLY) Could Change Following 33rd Straight Dividend Hike And Earnings Update — finance.yahoo.com.
🤖 The article highlights Wiley’s 33rd consecutive annual dividend increase and full-year net income, both of which signal financial strength. Even though revenue was only modest, the overall tone is constructive for $WLY because earnings and shareholder returns remain strong.
🍭 Bonus (B): 0/10 — Book Publishing

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 Current $31.89 is 0% below 3yr high $31.91 · ⏳ SMA200 $23.15 (current price $31.89 is above) · 💰 Market Cap $4.1B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (13.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 30% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (10.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 66 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Concentra Standout in Occupational Medicine: Analyst - Concentra Group Holdings (NYSE:CON) — Benzinga.
🤖 Benzinga reports an analyst-focused article highlighting Concentra’s strong first-quarter earnings beat, higher sales guidance, and a new 52-week high. These points are supportive for the stock because they reflect improving fundamentals and bullish market reaction.
✅ Concentra Group Holdings Parent (NYSE:CON) Sets New 52-Week High: Here’s What Happened — MarketBeat.
🤖 The article cites Concentra’s prior earnings beat, dividend declaration, and insider sale while noting the stock reached a new 52-week high. The earnings and dividend developments are supportive, though the insider sale adds some mixed context.
⚪️ Concentra to Announce Second Quarter 2026 Results on Thursday, August 6, 2026 — Yahoo Finance / Business Wire.
🤖 This is only a date announcement for an upcoming earnings release and conference call, with no actual results, guidance, or analyst view. Per the prompt, it is not material stock news and has been omitted from the item list.
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities

🏢 What they do: CSX Corporation is a holding company primarily operating CSX Transportation, a Class I freight railroad with over 21,000 miles of track in the eastern United States and parts of Canada. It transports commodities and manufactured goods, including merchandise freight (e.g., chemicals, metals, automotive), bulk freight, intermodal containers, and provides vehicle shipping services.
- 🎯 Current $51.80 is 3% below 3yr high $53.23 · ⏳ SMA200 $40.85 (current price $51.80 is above) · 💰 Market Cap $96.3B
- CSX shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 Low drawdown (11.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 23% (>20%); ROE 38% (>15%); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ CSX Corp. Announces Second Quarter 2026 Results — Yahoo Finance / Globe Newswire.
🤖 CSX reported Q2 2026 operating income of $1.51 billion and net earnings of $1.00 billion, or $0.54 per share, which is a clear fundamental update for the stock. The results were later described as record revenue with margin expansion and a raised outlook, which is supportive for shares.
✅ CSX Reports Q2 2026 Results: Full Earnings Call Transcript — Benzinga.
🤖 This article highlights stronger Q2 2026 revenue, profit, and volume growth, along with management’s decision to raise full-year 2026 guidance. Upward guidance revisions and improving operating metrics are positive for CSX.
✅ CSX (CSX) Exceeds Q2 CY2026 Expectations — Yahoo Finance.
🤖 CSX beat Wall Street estimates on both revenue and GAAP profit, and the stock traded higher immediately after the report. Earnings beats and an associated post-report share-price reaction are typically bullish for the stock.
🍭 Bonus (B): 0/10 — Railroads

🏢 What they do: SiriusXM Holdings Inc. is the leading audio entertainment company in North America, providing satellite radio, online streaming, and podcast content through its flagship subscription service SiriusXM and the ad-supported music streaming platform Pandora.
- 🎯 Current $31.22 is 61% below 3yr high $79.26 · ⏳ SMA200 $23.89 (current price $31.22 is above) · 💰 Market Cap $10.5B
- SIRI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 51/60
- 🏦 Low drawdown (9.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 22% (>20%); Low LT D/E 0.21 (<1.0); PEG ratio 0.60 (<1.5).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ Sirius XM (SIRI) Stock Trades Up, Here Is Why — Yahoo Finance.
🤖 Wells Fargo upgraded SIRI to Equal Weight from Underweight and raised its price target to $30 from $18, citing a much higher valuation for SiriusXM's spectrum assets. An upgrade and sharply higher target are generally positive for the stock.
✅ Sirius XM (NASDAQ:SIRI) Hits New 52-Week High — MarketBeat.
🤖 The stock reached a new 52-week high and the article highlights several analyst price-target increases and reiterations, including Wells Fargo's upgrade. New highs and improved analyst sentiment are supportive for SIRI.
⚪️ Should You Buy Sirius XM Stock Before July 30? | The Motley Fool — The Motley Fool.
🤖 This piece is mainly a pre-earnings opinion article, discussing recent performance and a YouTube partnership while framing the upcoming July 30 report as the key catalyst. It does not present a clear new bullish or bearish development on its own.
🍭 Bonus (B): 0/10 — Radio Broadcasting